Research Collaboration and License Agreement Between Palisade bio, Inc. And Giiant Pharma, Inc.Research Collaboration and License Agreement • September 8th, 2023 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 8th, 2023 Company Industry JurisdictionTHIS RESEARCH COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is made effective as of September 1, 2023 (“Effective Date”) by and between Palisade Bio, Inc. a Delaware corporation (“Palisade” or “Licensee”), with its principal place of business at 7750 El Camino Real, Suite 2A, Carlsbad, CA 92009, and Giiant Pharma Inc., a Canadian federal corporation (“Giiant” or “Licensor”), with its principal place of business at 2000-630 boul. René-Lévesque W., Montréal, Quebec H3B 1S6. Palisade and Giiant are sometimes referred to in this Agreement individually as a “Party” and collectively as the “Parties.”